Sensyne Health And Phesi Enter Joint Commercial Development Collaboration With A Leading Pharmaceutical Company
OXFORD, England & DOVER, Del.–(BUSINESS WIRE)–Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI company today announces that, together with its U.S. based strategic…